https://www.fiercebiotech.com/biotech/geron-craters-as-janssen-bows-out-imetelstat-pact-once-worth-up-to-935m
Geron shares crater as Janssen bows out of imetelstat pact once worth up to $935M | Fierce Biotech
Sep 27, 2018 - In 2014, Janssen handed over $35 million, with a promise of up to $900 million more, to partner with Geron on its telomerase inhibitor imetelstat.